Brain Health Program for Older Adults With Subjective Cognitive Decline

December 17, 2025 updated by: Ryan A., Mace, PHD, Massachusetts General Hospital

My Healthy Brain: A Group-Based Lifestyle Intervention to Modify Early Risk of Dementia in Older Adults

The investigators will compare two brain health programs in older adults with subjective cognitive decline and lifestyle risk factors for dementia. The primary aim of the study is to determine the credibility, expectancy, feasibility, acceptability, appropriateness, fidelity, and satisfaction of the programs.

Study Overview

Detailed Description

The investigators aim to promote brain health by reducing lifestyle risk factors for dementia in older adults with subjective cognitive decline (SCD). This study is a pilot randomized control trial (RCT) comparing two virtual lifestyle programs, My Healthy Brain 1 and My Healthy Brain 2. Eligible older adults include: age ≥ 60, self-reported worry about changes in memory or thinking, and risk factors for dementia (determined by the Cardiovascular Risk Factors, Aging, and Incidence of Dementia score ≥ 6). Participants will be randomized to one of two groups (My Healthy Brain 1 or My Healthy Brain 2) and will complete 8 weekly 90-minute sessions via Zoom delivered by a clinical psychologist. Each session will focus on a different topic relevant to brain health (e.g. physical activity, sleep, etc.). The primary aim of the study is to determine the credibility, expectancy, feasibility, acceptability, appropriateness, fidelity, and satisfaction of the programs. The investigators will also explore improvements in cognition, lifestyle behaviors (physical activity, sleep, nutrition, alcohol and tobacco use, social functioning), depression, anxiety, and mindfulness assessed at baseline, post-intervention, and 6 month follow-up. All participants will wear a watch to monitor changes in lifestyle during the program.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Concerns about memory or thinking (subjective cognitive decline, SCD) aged 60 or older
  • Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) ≥ 6
  • Telephone Interview for Cognitive Status-41 ≥ 31
  • Functional Assessment Questionnaire < 9
  • English fluency/literacy
  • Ability and willingness to participate via live video
  • No self-reported safety issues with initiating lifestyle changes during the study

Exclusion Criteria:

  • Mild cognitive impairment, dementia, or neurodegenerative disease
  • Psychotropic medications (e.g., antidepressant) change in the last 3 months
  • Psychosis, uncontrolled bipolar disorder or substance dependence; schizophrenia or schizoaffective disorder
  • Current self-report of suicidal ideation
  • Serious medical illness expected to worsen in 6 months (e.g., cancer)
  • Use of digital monitoring device (e.g., Fitbit) in the last 3 moths AND unwillingness to stop using personal digital monitoring device for duration of program
  • Mindfulness or mind-body practice (> 45 min/wk) focused on lifestyle, cognitive-behavioral therapy in < 3 months, or participation in a lifestyle prevention program (ex: diabetes prevention) in < 3 months
  • Average daily step count > 5,000 steps
  • More than 30 minutes of exercise daily

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: My Healthy Brain 1
My Healthy Brain 1 is an 8-week group program delivered via 90-minute Zoom meetings led by a clinical psychologist. It provides education on the link between dementia and lifestyle factors, including poor exercise, sleep, diet/nutrition, mental and social stimulation, alcohol, and smoking. My Healthy Brain 1 participants learn evidence-based mindfulness and behavior change skills to address common barriers to healthy habits, such as stress and setting achievable goals. My Healthy Brain 1 participants wear an activity watch to monitor lifestyle changes during the program.
My Healthy Brain 1 is an 8-week group program delivered via 90-minute Zoom meetings led by a clinical psychologist. It provides education on the link between dementia and lifestyle factors, including poor exercise, sleep, diet/nutrition, mental and social stimulation, alcohol, and smoking. My Healthy Brain 1 participants learn evidence-based mindfulness and behavior change skills to address common barriers to healthy habits, such as stress and setting achievable goals. My Healthy Brain 1 participants wear an activity watch to monitor lifestyle changes during the program.
Active Comparator: My Healthy Brain 2
My Healthy Brain 2 condition controls for the effect of time spent and support/feedback from the group and interventionist. Participants in My Healthy Brain 2 will receive education on lifestyle, brain health, and cognitive decline symptoms in addition to usual care as determined by their medical team. Each weekly session will focus on a different topic: 1) lifestyle and brain health, 2) physical activity, 3) sleep, 4) nutrition, 5) medical adherence, 6) cognitive health, 7) social support, and 8) a program overview. My Healthy Brain 2 is conducted in the same format as My Healthy Brain 1 (8 weekly Zoom sessions, 90 minutes each), but does not include behavior change strategies. My Healthy Brain 2 participants wear an activity watch to monitor lifestyle changes during the program.
My Healthy Brain 2 condition controls for the effect of time spent and support/feedback from the group and interventionist. Participants in My Healthy Brain 2 will receive education on lifestyle, brain health, and cognitive decline symptoms in addition to usual care as determined by their medical team. Each weekly session will focus on a different topic: 1) lifestyle and brain health, 2) physical activity, 3) sleep, 4) nutrition, 5) medical adherence, 6) cognitive health, 7) social support, and 8) a program overview. My Healthy Brain 2 is conducted in the same format as My Healthy Brain 1 (8 weekly Zoom sessions, 90 minutes each), but does not include behavior change strategies. My Healthy Brain 2 participants wear an activity watch to monitor lifestyle changes during the program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Credibility and Expectancy Questionnaire
Time Frame: 0 Weeks
Assesses how believable, convincing, and logical patients perceive the treatment to be. Higher scores (min = 3, max = 27) scores indicate greater credibility and expectancy.
0 Weeks
Client Satisfaction Questionnaire
Time Frame: 8 Weeks
Assesses patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction.
8 Weeks
Rates of Recruitment and Enrollment
Time Frame: 0 Weeks
We will assess the feasibility of recruiting and enrolling participants into the study by calculating the proportion who agree to participate divided by the total number contacted (≥70% good, ≥ 80% excellent).
0 Weeks
Rates of Missing Outcomes Data
Time Frame: 8 Weeks
We will assess the feasibility of data collection by calculating the proportion of secondary outcomes (cognition and lifestyle) with no missing data divided by the total number collected (≥70% good, ≥ 80% excellent).
8 Weeks
Rates of Treatment Completion
Time Frame: 8 Weeks
We will assess the acceptability of treatment by calculating the proportion of participants who attend ≥ 6/8 treatment sessions (≥ 70% good, ≥ 80% excellent).
8 Weeks
Rates of Therapist Fidelity to Intervention Procedures
Time Frame: 8 Weeks
We will assess the fidelity of therapists to the intervention procedures by calculating the proportion of sessions with completed audio recordings, progress notes, and checklist with 100% of content delivered divided by the total number of sessions (≥ 75% good, 100% excellent).
8 Weeks
Rates of Staff Fidelity to Study Procedures
Time Frame: 8 Weeks
We will assess the fidelity of staff to the study procedures by counting the frequency of protocol deviations (<5 deviations good, 0 deviations excellent).
8 Weeks
Modified Patient Global Impression of Change at 8 weeks
Time Frame: 8 Weeks
The proportion of participants who report perceived improvements in cognitive function, lifestyle, and emotional well-being outcomes (1=Very Much Worse, 7=Very Much Improved).
8 Weeks
Rate of Adverse Events
Time Frame: 8 Weeks
We will assess the safety of the study by founding the number and severity of adverse events (mild in ≤ 10% of participants = good, none = excellent).
8 Weeks
Rates of Valid Activity Watch Data (10 or more hours of wear time)
Time Frame: 8 Weeks
We will assess the feasibility of collecting valid activity watch data by calculating the proportion of participants who wore the watch at least 5 out of 7 days per week for at least 10 or more hours per day, divided by the total number of days in the program (≥ 70% good, ≥ 80% excellent).
8 Weeks
Rates of Ecological Momentary Assessment (EMA) Data
Time Frame: 8 Weeks
We will assess the feasibility of collecting ecological momentary assessment (EMA) of daily mindfulness practice by calculating the proportion of participants who complete at least 5 out of 7 daily surveys per week (≥ 70% good, ≥ 80% excellent).
8 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Time Frame: 0 Weeks, 8 Weeks, 6 Months
A comprehensive test of five cognitive domains (immediate memory, visuospatial/constructional, language, attention, and delayed memory) and global cognition. Higher Z and Index Scores indicate greater cognitive functioning on each domain.
0 Weeks, 8 Weeks, 6 Months
Cognitive Function Instrument
Time Frame: 0 Weeks, 8 Weeks, 6 Months
14-item self-report of cognitive and functional status. Higher total scores (min=0, max=14) indicate greater subjective cognitive complaints.
0 Weeks, 8 Weeks, 6 Months
Change in Step Count
Time Frame: 0 Weeks, 8 Weeks, 6 Months
Activity watch change in steps count during the 7 days preceding baseline assessment, throughout the intervention period, and 7 days at 6-month follow-up. Higher step count totals indicate greater physical activity (walking).
0 Weeks, 8 Weeks, 6 Months
PROMIS Physical Function
Time Frame: 0 Weeks, 8 Weeks, 6 Months
8-item self-report of daily functioning. Higher T scores (mean = 50, sd = 10) indicate greater physical function.
0 Weeks, 8 Weeks, 6 Months
Change in Total Sleep Time
Time Frame: 0 Weeks, 8 Weeks, 6 Months
Activity watch change in total sleep time during the 7 days preceding baseline assessment, throughout the intervention period, and 7 days at 6-month follow-up. Higher total minutes indicate greater sleep time.
0 Weeks, 8 Weeks, 6 Months
Mediterranean Eating Pattern for Americans Screener
Time Frame: 0 Weeks, 8 Weeks, 6 Months
16-item self-report of adherence to Mediterranean dietary recommendations. Higher total scores (min=0, max=21) indicate greater intake/adherence of Mediterranean foods.
0 Weeks, 8 Weeks, 6 Months
PROMIS Alcohol Use
Time Frame: 0 Weeks, 8 Weeks, 6 Months
7-item self-report of at-risk drinking. Higher T scores (mean = 50, sd = 10) indicate greater problematic alcohol use.
0 Weeks, 8 Weeks, 6 Months
CDC Other Tobacco Product Use Questions
Time Frame: 0 Weeks, 8 Weeks, 6 Months
2-item self-report of the frequency and use of 6 common tobacco products (1=Less than once a month, 5=Daily or almost daily).
0 Weeks, 8 Weeks, 6 Months
PROMIS Satisfaction with Social Roles and Activities
Time Frame: 0 Weeks, 8 Weeks, 6 Months
8-item self-report measure of satisfaction of performing usual social roles and activities. Higher T scores (mean = 50, sd = 10) indicate greater satisfaction with social roles and activities.
0 Weeks, 8 Weeks, 6 Months
Pittsburgh Sleep Quality Index
Time Frame: 0 Weeks, 8 Weeks, 6 Months
9-item self-report of sleep patterns and overall quality. Higher total scores (min=0, max=21) indicate greater sleep disturbance (>5 = clinically significant).
0 Weeks, 8 Weeks, 6 Months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of Cognitive Activities
Time Frame: 0 Weeks, 8 Weeks, 6 Months
10-item self-report measure of frequency of certain cognitive activities (e.g. reading newspapers, playing music, etc). Higher total scores (min=0, max=10) indicate greater participation in cognitively stimulating activities.
0 Weeks, 8 Weeks, 6 Months
Memory Compensation Questionnaire
Time Frame: 0 Weeks, 8 Weeks, 6 Months
13-item self-report that assesses the variety and extent to which an individual compensates for actual or perceived memory losses. Higher total scores (min=0, max=65) indicate greater utilization of memory compensation strategies.
0 Weeks, 8 Weeks, 6 Months
Godin Leisure-Time Exercise Questionnaire
Time Frame: 0 Weeks, 8 Weeks, 6 Months
3-item self-report of weekly engagement in light, moderate, and vigorous physical activities. Higher average scores indicate greater engagement in total physical activity.
0 Weeks, 8 Weeks, 6 Months
Social Engagement and Activities Questionnaire
Time Frame: 0 Weeks, 8 Weeks, 6 Months
10-item self-report measure of perceived frequency of specific social activities. Higher total scores (min=0, max=50) indicate greater participation in socially engaging activities.
0 Weeks, 8 Weeks, 6 Months
PROMIS Loneliness
Time Frame: 0 Weeks, 8 Weeks, 6 Months
5-item self-report of perceived loneliness. Higher T scores (mean = 50, sd = 10) indicate greater perceived loneliness.
0 Weeks, 8 Weeks, 6 Months
PROMIS Depression and Anxiety
Time Frame: 0 Weeks, 8 Weeks, 6 Months
4-item self-reports of each construct. Higher T scores (mean = 50, sd = 10) indicate greater depression and anxiety.
0 Weeks, 8 Weeks, 6 Months
Applied Mindfulness Process Scale
Time Frame: 0 Weeks, 8 Weeks, 6 Months
15-item self-report of using basic mindfulness principles. Higher total scores (min=0, max=60) indicate greater utilization in daily mindfulness activities.
0 Weeks, 8 Weeks, 6 Months
Cognitive Control and Flexibility Questionnaire
Time Frame: 0 Weeks, 8 Weeks, 6 Months
13-item self-report of control over unwanted experiences. Higher total scores (min=13, max=52) indicate greater daily utilization of cognitive control and flexibility.
0 Weeks, 8 Weeks, 6 Months
Emotion Regulation Questionnaire
Time Frame: 0 Weeks, 8 Weeks, 6 Months
10-item self-report of emotion regulation strategies. Higher total scores (min=10, max=70) indicate greater utilization of emotional regulation strategies.
0 Weeks, 8 Weeks, 6 Months
Motivation to Change Lifestyle and Health Behaviours for Dementia Risk Reduction
Time Frame: 0 Weeks, 8 Weeks, 6 Months
27-item self report of motivation and perceived self-efficacy of lifestyle and health behavior change for dementia risk reduction. Higher total scores (min=27, max=135) indicate greater motivation to alter lifestyle factors and health behaviors to reduce risk of dementia.
0 Weeks, 8 Weeks, 6 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 16, 2024

Primary Completion (Actual)

November 7, 2025

Study Completion (Actual)

November 7, 2025

Study Registration Dates

First Submitted

June 22, 2023

First Submitted That Met QC Criteria

July 5, 2023

First Posted (Actual)

July 6, 2023

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Lifestyle

Clinical Trials on My Healthy Brain 1

Subscribe